FDA OKs First Non-Antipsychotic for Alzheimer’s Agitation
The FDA has approved Auvelity for AD agitation. The combination of dextromethorphan and bupropion is the first oral non-antipsychotic approved for this indication. Medscape Medical News source https://www.medscape.com/viewarticle/fda-oks-first-non-antipsychotic-alzheimers-agitation-2026a1000dze?src=rss